Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$464.3K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,250 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | AGRANT◷◆ | 8,500 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,250 | — | — | +3.6% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,014 | $42.61 | $43.2K | -0.9% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 7,239 | $41.93 | $303.5K | -5.8% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 9 | $41.07 | $370 | <0.1% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 65 | $28.85 | $1.9K | <0.1% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | AGRANT◷ | 14,000 | — | — | +12.6% | Open the original filing on SEC.gov |